Chemed Co. (NYSE:CHE) Shares Bought by XTX Topco Ltd

XTX Topco Ltd lifted its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 111.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,843 shares of the company's stock after buying an additional 1,499 shares during the period. XTX Topco Ltd's holdings in Chemed were worth $1,709,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. SG Americas Securities LLC boosted its holdings in Chemed by 422.9% in the second quarter. SG Americas Securities LLC now owns 7,551 shares of the company's stock worth $4,097,000 after purchasing an additional 6,107 shares during the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Chemed by 110.0% during the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company's stock valued at $5,801,000 after buying an additional 5,572 shares during the period. Evergreen Capital Management LLC bought a new stake in shares of Chemed in the second quarter worth $7,812,000. Quest Partners LLC grew its holdings in shares of Chemed by 634.3% in the second quarter. Quest Partners LLC now owns 1,990 shares of the company's stock worth $1,080,000 after acquiring an additional 1,719 shares during the period. Finally, Envestnet Asset Management Inc. boosted its position in Chemed by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 74,461 shares of the company's stock worth $40,401,000 after purchasing an additional 1,106 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CHE. Royal Bank of Canada cut their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.

Insider Activity at Chemed

In other Chemed news, Director George J. Walsh III sold 400 shares of the company's stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. This represents a 11.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares of the company's stock, valued at $3,478,159.15. The trade was a 21.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,845 shares of company stock worth $3,978,798 in the last 90 days. 3.32% of the stock is owned by corporate insiders.

Chemed Price Performance

Shares of Chemed stock traded down $3.41 during trading on Friday, hitting $552.62. The stock had a trading volume of 81,657 shares, compared to its average volume of 78,987. The stock has a market cap of $8.32 billion, a PE ratio of 27.92, a PEG ratio of 2.42 and a beta of 0.46. Chemed Co. has a 12 month low of $523.33 and a 12 month high of $654.62. The firm's fifty day simple moving average is $574.95 and its 200-day simple moving average is $565.03.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $606.18 million for the quarter, compared to analysts' expectations of $612.22 million. During the same quarter in the previous year, the firm earned $5.32 EPS. Chemed's revenue was up 7.4% compared to the same quarter last year. Analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed's payout ratio is 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.